Purpose: We used new criteria to elucidate the demographics of acute low-tone sensorineural hearing loss (ALHL) and tested the Chinese medicine Wu-Ling-San as a treatment for ALHL. Procedures: We reviewed the medical records of patients with ALHL seen at the outpatient clinic of the Social Insurance Central General Hospital in Tokyo from April 2006 through August 2011. Patients were treated with an oral steroid, a diuretic, or Wu-Ling-San; alone or in combination. Results: We identified 130 definite and 48 probable ALHL cases. The mean age and male-to-female ratio in probable cases were significantly higher than those in definite cases (p < 0.05). The steroid-Wu-Ling-San combination was significantly more effective (100% recovery) than the diuretic alone (59%), Wu-Ling-San alone (62%), or the steroid-diuretic combination (60%, p < 0.05). Conclusions: ALHL can develop in older patients more frequently than we expected. The steroid-Wu-Ling-San combination is a possible new treatment for ALHL.

Keywords:
Acute low-tone hearing loss, Steroid, Wu-Ling-San, Diuretics
1.
Fuse T, Aoyagi M, Funakubo T, Sakakibara A, Yoshida S: Short-term outcome and prognosis of acute low-tone sensorineural hearing loss by administration of steroid. ORL 2002;64:6–10.
2.
Kitajiri SI, Tabuchi K, Hiraumi H, Hirose T: Is corticosteroid therapy effective for sudden-onset sensorineural hearing loss at lower frequencies? Arch Otolaryngol Head Neck Surg 2002;128:365–367.
3.
Morita S, Suzuki M, Iizuka K: A comparison of the short-term outcome in patients with acute low-tone sensorineural hearing loss. ORL 2010;72:295–299.
4.
Imamura S, Nozawa I, Imamura M, Murakami Y: Clinical observations on acute low-tone sensorineural hearing loss. Survey and analysis of 137 patients. Ann Otol Rhinol Laryngol 1997;106:746–750.
5.
Yamasoba T, Kikuchi S, Sugasawa M, Yagi M, Harada T: Acute low-tone sensorineural hearing loss without vertigo. Arch Otolaryngol Head Neck Surg 1994;120:532–535.
6.
Noguchi Y, Nishida H, Tokano H, Kawashima Y, Kitamura K: Comparison of acute low-tone sensorineural hearing loss versus Ménière’s disease by electrocochleography. Ann Otol Rhinol Laryngol 2004;113:194–199.
7.
Nozawa I, Imamura S-I, Mizukoshi A, Honda H, Okamoto Y: Clinical study of acute low-tone sensorineural hearing loss: survey and analysis of glycerol test and orthostatic test. Ann Otol Rhinol Laryngol 2002;111:160–164.
8.
Gottschlich S, Billings PB, Keithley EM, Weisman MH, Harris JP: Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Ménière’s disease. Laryngoscope 1995;105:1347–1352.
9.
Fuse T, Hayashi T, Oota N, et al: Immunological responses in acute low-tone sensorineural hearing loss and Ménière’s disease. Acta Otolaryngol 2003;123:26–31.
10.
Suzuki M, Otake R, Kashio A: Effect of corticosteroids or diuretics in low-tone sensorineural hearing loss. ORL 2006;68:170–176.
11.
Abe T: Acute sensorineural hearing loss in low tone frequencies. Otolaryngology (Tokyo) 1982;54:385–392.
12.
Selivanova OA, Gouveris H, Victor A, Amedee RG, Mann W: Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière’s-associated sudden sensorineural hearing loss. Otol Neurotol 2005;26:890–895.
13.
Ye KF: Treating 86 cases of Ménière’s syndrome with Wu Ling San. J New TCM 1999;31:43–44.
14.
Hirata K: Two cases of Ménière’s disease to which Wu-Ling-San showed higher efficacy (in Japanese). Prog Med 1994;14:3238–3239.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.